---
status: passed
---

# Phase 211 Verification

## Outcome

Phase `211` delivered the separate ARC-Wall CLI surface, one bounded
control-path guard evaluation, one ARC evidence export path, and one
buyer-facing package family without routing ARC-Wall through MERCURY.

## Evidence

- [Cargo.toml](/Users/connor/Medica/backbay/standalone/arc/crates/arc-wall/Cargo.toml)
- [main.rs](/Users/connor/Medica/backbay/standalone/arc/crates/arc-wall/src/main.rs)
- [commands.rs](/Users/connor/Medica/backbay/standalone/arc/crates/arc-wall/src/commands.rs)
- [cli.rs](/Users/connor/Medica/backbay/standalone/arc/crates/arc-wall/tests/cli.rs)
- [README.md](/Users/connor/Medica/backbay/standalone/arc/docs/arc-wall/README.md)

## Validation

- `cargo fmt --all`
- `CARGO_BUILD_JOBS=1 CARGO_INCREMENTAL=0 cargo check -p arc-wall-core -p arc-wall`
- `CARGO_BUILD_JOBS=1 CARGO_INCREMENTAL=0 cargo test -p arc-wall --test cli`

## Requirement Closure

`AWALL-03` and `AWALL-04` are now satisfied locally: ARC-Wall supports one
bounded control-path guard and packaging surface while remaining a separate
companion product on ARC rather than a MERCURY lane or generic barrier
platform.

## Next Step

Phase `212` can now generate the real validation corpus, operations package,
and explicit expansion decision.
